Cannabis for orthopaedic pain is a growing topic, but this 2025 systematic review does not settle the question. It found mixed signals across small, heterogeneous trials, with more placebo-controlled wins than active-comparator wins. For clinicians and patients alike, cannabis for orthopaedic pain remains promising in spots, but far from standardized.